National HealthCare Corporation (NHC)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
223.70 - Open
225.69 - Bid 208.00 x 20000
- Ask --
- Day's Range
210.62 - 224.30 - 52 Week Range
118.14 - 248.20 - Volume
434 - Avg. Volume
114,018 - Market Cap (intraday)
3.317B - Beta (5Y Monthly) 0.61
- PE Ratio (TTM)
23.83 - EPS (TTM)
8.89 - Earnings Date (est.) Nov 6, 2026
- Forward Dividend & Yield 2.68 (1.27%)
- Ex-Dividend Date Sep 30, 2026
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/28/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
3.32B
-
Enterprise Value
3.14B
-
Trailing P/E
23.83
-
Forward P/E
--
-
PEG Ratio (current)
3.92
-
Price/Sales (ttm)
2.14
-
Price/Book (mrq)
2.96
-
Enterprise Value/Revenue
2.02
-
Enterprise Value/EBITDA
14.03
Financial Highlights
Profitability and Income Statement
-
Profit Margin
9.00%
-
Return on Assets (ttm)
5.84%
-
Return on Equity (ttm)
13.27%
-
Revenue (ttm)
1.56B
-
Net Income Avi to Common (ttm)
140.26M
-
Diluted EPS (ttm)
8.89
Balance Sheet and Cash Flow
-
Total Cash (mrq)
210.19M
-
Total Debt/Equity (mrq)
2.78%
-
Levered Free Cash Flow (ttm)
63.17M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Company Insights
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports
View More-
Raising target price to $273.00
NATIONAL HEALTHCARE CORP has an Investment Rating of BUY; a target price of $273.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.
-
Raising target price to $255.00
NATIONAL HEALTHCARE CORP has an Investment Rating of BUY; a target price of $255.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.
-
Raising target price to $251.00
NATIONAL HEALTHCARE CORP has an Investment Rating of BUY; a target price of $251.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.
-
Raising target price to $247.00
NATIONAL HEALTHCARE CORP has an Investment Rating of BUY; a target price of $247.000000; an Industry Subrating of Medium; a Management Subrating of High; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of High.


